Latent class analysis identifies functional decline with Amsterdam IADL in preclinical Alzheimer's disease - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Alzheimer's & Dementia : the Journal of the Alzheimer's Association Année : 2019

Latent class analysis identifies functional decline with Amsterdam IADL in preclinical Alzheimer's disease

Résumé

Introduction: Trials in Alzheimer's disease (AD) now include participants at the earliest stages to prevent further decline. However, the lack of tools sensitive to subtle functional changes in early-stage AD hinders the development of new therapies as it is difficult to prove their clinical relevance. Methods: We assessed functional changes over three years in 289 elderly memory complainers from the Investigation of Alzheimer's Predictors in subjective memory complainers cohort using the Am-sterdam Instrumental-Activities-of-Daily-Living questionnaire (A-IADL-Q). Results: No overall functional decline related to AD imaging markers was evidenced. However, five distinct classes of A-IADL-Q trajectories were identified. The largest class (212 [73.4%]) had stable A-IADL-Q scores over 3 years. A second group (23 [8.0%]) showed a persistent functional decline, higher amyloid load (P 5 .0005), and lower education (P 5 .0392). Discussion: The A-IADL-Q identified a subtle functional decline in asymptomatic at-risk AD individuals. This could have important implications in the field of early intervention in AD.
Fichier principal
Vignette du fichier
Villeneuve et al 2019 Latent class analysis identifies functional decline with Amsterdam IADL in preclinical Alzheimer's disease ALZ AND DEM TRCI.pdf (1.17 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

hal-02333456 , version 1 (25-10-2019)

Identifiants

Citer

Sarah-Christine Villeneuve, Marion Houot, Federica Cacciamani, Merike Verrijp, Bruno Dubois, et al.. Latent class analysis identifies functional decline with Amsterdam IADL in preclinical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 2019, 5, pp.553-562. ⟨10.1016/j.trci.2019.08.009⟩. ⟨hal-02333456⟩
130 Consultations
105 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More